seed
Stage
1
Investors
About
Develops a next-generation sequencing platform that combines silicon-based detection with enzyme-based sequencing chemistry to deliver ultrafast, lower-cost DNA and RNA sequencing. Aims to commoditize sequencing and enable use outside large centralized facilities.
Explore Stream Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.